Cagliari, Italy

Stefania Ruiu

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Stefania Ruiu: A Trailblazer in Pharmaceutical Innovations**

Introduction

Stefania Ruiu, an innovative inventor based in Cagliari, Italy, has made significant contributions to the field of pharmacology. With an impressive portfolio of six patents, her work focuses primarily on diazabicyclic compounds and their potential applications in targeting opioidergic receptors.

Latest Patents

Among her latest patents are groundbreaking discoveries related to substituted 3,8-diazabicyclo[3.2.1]octane compounds. These diazapolycyclic compounds demonstrate affinity for opioidergic receptors, particularly the delta opioidergic receptors, showcasing both central and peripheral activity. Her work also includes pharmaceutical compounds involving nonane and decane diazabicyclic derivatives that have homopiperazine as a main ring. These compounds also exhibit an affinity for opioid receptors, indicating a vast potential for therapeutic applications.

Career Highlights

Throughout her career, Stefania has been associated with Neuroscienze Pharmaness, a company that underscores her commitment to advancing pharmaceutical innovations. Her expertise and dedication to research have cemented her reputation as an influential figure in her field.

Collaborations

Stefania has collaborated with notable professionals, including colleagues Paolo Lazzari and Gerard Aime Pinna. These collaborations enhance her innovative efforts and facilitate the development of new pharmaceutical solutions to address urgent medical needs.

Conclusion

In conclusion, Stefania Ruiu stands out as a remarkable inventor whose contributions to pharmacology represent the forefront of medical innovation. Her extensive patent portfolio not only embodies her dedication to research but also reflects her commitment to developing solutions that could potentially transform pain management therapies. With each discovery, she paves the way for new treatments and advances the scientific community's understanding of pharmacological compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…